ARGOS THERAPEUTICS INC — Form D

ARGOS THERAPEUTICS INC of DURHAM, NC, a company, filed a Form D exempt-offering notice with the SEC on 2012-09-11. The offering totals $16.0M, of which $16.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (29)

Showing 25 of 29 people.

NameRoleLocation
Jeffrey D. AbbeyDirectorDurham, NC
Hubert D. BirnerDirectorBoston, MA
David A. GryskaDirectorCarmel, CA
Philip R. TracyDirectorDurham, NC
Brian R. UnderdownDirectorToronto, A6
Sander D. van DeventerDirectorNaarden, P7
Jeffrey D. AbbeyExecutive OfficerDurham, NC
Lori A. HarrelsonExecutive OfficerDurham, NC
Frederick M. MiesowiczExecutive OfficerDurham, NC
Charles A. NicoletteExecutive OfficerDurham, NC
Douglas A. PlessingerExecutive OfficerDurham, NC
David A GryskaDirectorNew York, NY
B. Jefferson ClarkDirectorDurham, NC
Philip R TracyDirectorDurham, NC
Hubert D BirnerDirectorWaltham, MA
Jeffrey D AbbeyDirectorDurham, NC
Jeffrey D AbbeyExecutive OfficerDurham, NC
Andrei A PetrovDirectorMoscow, 1Z
Lori A HarrelsonExecutive OfficerDurham, NC
Charles A NicoletteExecutive OfficerDurham, NC
Frederick M MiesowiczExecutive OfficerDurham, NC
Brian R UnderdownDirectorToronto, A6
Douglas A PlessingerExecutive OfficerDurham, NC
Sander D van DeventerDirectorNaarden, P7
Jean A LamarreDirectorMontreal, A8

Other filings by this issuer (4)

FiledFormOfferingSold
2013-08-27D$60.0M$22.0M
2012-04-24D$50.0M$9.0M
2011-07-29D$3.5M$3.5M
2010-09-20D$6.0M$4.9M

More